Want to join the conversation?
Matthew Cabral of Goldman Sachs asks about M&A. $XRX said it has $100MM in its plans for M&A and the plans are modest for 2016. The company has acquired $18MM YTD and has plans to spend the $100MM in Doc Tech for distribution and in Services, for small tuck-in acquisitions in important areas.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.